Vistin Pharma ASA (OSL:VISTN)

Market Cap	993.32M -6.7%
Revenue (ttm)	449.47M +2.0%
Net Income	74.55M -2.9%
EPS	1.68 -3.0%
Shares Out	44.34M
PE Ratio	13.33
Forward PE	n/a
Dividend	1.50 (6.70%)
Ex-Dividend Date	May 22, 2026

Volume	3,836
Average Volume	33,440
Open	22.20
Previous Close	22.40
Day's Range	22.20 - 22.60
52-Week Range	19.40 - 26.40
Beta	0.62
RSI	51.63
Earnings Date	Apr 24, 2026

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1969
• Employees: 77
• Stock Exchange: Oslo Børs
• Ticker Symbol: VISTN

Financial Performance

In 2025, Vistin Pharma ASA's revenue was 452.29 million, an increase of 5.31% compared to the previous year's 429.50 million. Earnings were 74.75 million, an increase of 19.13%.